P1.02. HRA00129-C004, a Novel c-Met ADC with Promising Preclinical Anti-tumor Activity and Expanded Therapeutic Window - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Yunan Tian
Meta Tag
Speaker Yunan Tian
Topic Tumor Biology: Preclinical Biology - Molecular Therapeutic Targets
c-Met targeted Antibody Drug Conjugate
preclinical anti-tumor activity
solid tumor types
ADC development
binding affinity
lung cancer cells
anti-tumor efficacy
Pharmacokinetic studies
clinical testing
Powered By